CPRX
Price
$23.01
Change
+$0.23 (+1.01%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.8B
125 days until earnings call
Intraday BUY SELL Signals
IRON
Price
$87.08
Change
+$1.06 (+1.23%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
3.25B
134 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CPRX vs IRON

Header iconCPRX vs IRON Comparison
Open Charts CPRX vs IRONBanner chart's image
Catalyst Pharmaceuticals
Price$23.01
Change+$0.23 (+1.01%)
Volume$19.82K
Capitalization2.8B
Disc Medicine
Price$87.08
Change+$1.06 (+1.23%)
Volume$7.27K
Capitalization3.25B
CPRX vs IRON Comparison Chart in %
CPRX
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CPRX vs. IRON commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Buy and IRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CPRX: $22.78 vs. IRON: $86.02)
Brand notoriety: CPRX and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 92% vs. IRON: 46%
Market capitalization -- CPRX: $2.8B vs. IRON: $3.25B
CPRX [@Biotechnology] is valued at $2.8B. IRON’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 2 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • CPRX’s FA Score: 2 green, 3 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, CPRX is a better buy in the long-term than IRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 5 TA indicator(s) are bullish while IRON’s TA Score has 4 bullish TA indicator(s).

  • CPRX’s TA Score: 5 bullish, 4 bearish.
  • IRON’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than IRON.

Price Growth

CPRX (@Biotechnology) experienced а +6.55% price change this week, while IRON (@Biotechnology) price change was -2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

CPRX is expected to report earnings on Mar 18, 2026.

IRON is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($3.25B) has a higher market cap than CPRX($2.8B). IRON YTD gains are higher at: 35.678 vs. CPRX (9.152). CPRX has higher annual earnings (EBITDA): 281M vs. IRON (-142.42M). CPRX (653M) and IRON (650M) have equal amount of cash in the bank . CPRX has less debt than IRON: CPRX (2.99M) vs IRON (30.9M). CPRX has higher revenues than IRON: CPRX (558M) vs IRON (0).
CPRXIRONCPRX / IRON
Capitalization2.8B3.25B86%
EBITDA281M-142.42M-197%
Gain YTD9.15235.67826%
P/E Ratio13.32N/A-
Revenue558M0-
Total Cash653M650M100%
Total Debt2.99M30.9M10%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
33
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CPRXIRON
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 22 days ago
67%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRCX44.240.24
+0.55%
MFS International Growth C
FBBAX27.150.06
+0.22%
First Foundation Total Return A
PTMCX20.200.03
+0.15%
PGIM Quant Solutions Large-Cap Cor Eq C
CGOCX21.83-0.02
-0.09%
Columbia Small Cap Growth C
SLAFX37.51-0.14
-0.37%
DWS Latin America Equity S

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
-1.39%
VIR - CPRX
49%
Loosely correlated
N/A
SANA - CPRX
48%
Loosely correlated
-4.25%
IRON - CPRX
43%
Loosely correlated
-0.06%
NRIX - CPRX
43%
Loosely correlated
-5.37%
DNLI - CPRX
42%
Loosely correlated
-0.34%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with RVMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
-0.06%
RVMD - IRON
54%
Loosely correlated
+2.73%
KMSTF - IRON
54%
Loosely correlated
N/A
XNCR - IRON
51%
Loosely correlated
-3.23%
SYRE - IRON
51%
Loosely correlated
+0.34%
NUVL - IRON
51%
Loosely correlated
+0.91%
More